Impulse magnetic-field therapy for erectile dysfunction: A double-blind, placebo-controlled study

被引:0
作者
Rainer B. Pelka
Christof Jaenicke
Joerg Gruenwald
机构
[1] Universität der Bundeswehr München,PhytoPharm Consulting
[2] Institute for Phytopharmaceuticals,undefined
来源
Advances in Therapy | 2002年 / 19卷
关键词
erectile dysfunction; magnetic waves; alternative therapy; impulse magnetic-field therapy;
D O I
暂无
中图分类号
学科分类号
摘要
This double-blind, placebo-controlled study assessed the efficacy of 3 weeks of impulse magnetic-field therapy for erectile dysfunction (ED). Twenty volunteers who suffered from ED or orgasmic disturbances were randomly assigned to either active treatment or placebo (n = 10 each). Efficacy was assessed in terms of intensity and duration of erection, general well-being, sexual activity, and warm sensation in the genital area. In the active-treatment group, all efficacy endpoints were significantly improved at study end (P=.01), with 80% reporting increases in intensity and duration of erection, frequency of genital warmth, and general wellbeing. The remaining 20%, who experienced minor improvements, were found to have an influenza-like infection after the study that may have influenced their results. Only 30% of the placebo group noted some improvement in their sexual activity; 70% had no change. No side effects were reported.
引用
收藏
页码:53 / 60
页数:7
相关论文
共 74 条
[1]  
Korenman SG(1998)New insights into erectile dysfunction: a practical approach Am J Med 105 135-144
[2]  
Virag R(1997)Nosology, epidemiology, clinical quantification of erectile dysfunction Rev Med Int 1 10-13
[3]  
Beck-Archily L(1997)Prevalence of sexual dysfunction in heterosexual patients attending a central London genitourinary medicine clinic Int J STD AIDS 8 303-306
[4]  
Goldmeier D(1997)Sexual dysfunction in primary care. Prevalence, characteristics and detection by the general practitioner J Public Health Med 19 387-391
[5]  
Keane FE(2000)The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction Am J Cardiol. 86 41-45
[6]  
Carter P(1999)Drug-related erectile dysfunction Adverse Drug React Toxicol Rev 18 5-24
[7]  
Hessman A(1998)Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations Int Clin Psychopharmacol 13 27-33
[8]  
Harris JRW(2000)Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 56 302-306
[9]  
Renton A(1999)The epidemiology and pathophysiology of erectile dysfunction J Urol 161 5-11
[10]  
Read S(2000)Non-surgical management of erectile dysfunction Clin Endocrinol 52 263-270